BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17597614)

  • 1. Prediction of three different isoforms of the human UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase.
    Reinke SO; Hinderlich S
    FEBS Lett; 2007 Jul; 581(17):3327-31. PubMed ID: 17597614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation and pathophysiological implications of UDP-GlcNAc 2-epimerase/ManNAc kinase (GNE) as the key enzyme of sialic acid biosynthesis.
    Reinke SO; Lehmer G; Hinderlich S; Reutter W
    Biol Chem; 2009 Jul; 390(7):591-9. PubMed ID: 19426133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis of N-acetylneuraminic acid in cells lacking UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase.
    Hinderlich S; Berger M; Keppler OT; Pawlita M; Reutter W
    Biol Chem; 2001 Feb; 382(2):291-7. PubMed ID: 11308027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domain-specific characteristics of the bifunctional key enzyme of sialic acid biosynthesis, UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase.
    Blume A; Weidemann W; Stelzl U; Wanker EE; Lucka L; Donner P; Reutter W; Horstkorte R; Hinderlich S
    Biochem J; 2004 Dec; 384(Pt 3):599-607. PubMed ID: 15330759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a cell-free system to determine UDP-N-acetylglucosamine 2-epimerase and N-acetylmannosamine kinase activities in human hereditary inclusion body myopathy.
    Sparks SE; Ciccone C; Lalor M; Orvisky E; Klootwijk R; Savelkoul PJ; Dalakas MC; Krasnewich DM; Gahl WA; Huizing M
    Glycobiology; 2005 Nov; 15(11):1102-10. PubMed ID: 15987957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for dynamic interplay of different oligomeric states of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase by biophysical methods.
    Ghaderi D; Strauss HM; Reinke S; Cirak S; Reutter W; Lucka L; Hinderlich S
    J Mol Biol; 2007 Jun; 369(3):746-58. PubMed ID: 17448495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The homozygous M712T mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase results in reduced enzyme activities but not in altered overall cellular sialylation in hereditary inclusion body myopathy.
    Hinderlich S; Salama I; Eisenberg I; Potikha T; Mantey LR; Yarema KJ; Horstkorte R; Argov Z; Sadeh M; Reutter W; Mitrani-Rosenbaum S
    FEBS Lett; 2004 May; 566(1-3):105-9. PubMed ID: 15147877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of UDP-GlcNAc 2-epimerase/ManNAc kinase mutant proteins on hereditary inclusion body myopathy.
    Penner J; Mantey LR; Elgavish S; Ghaderi D; Cirak S; Berger M; Krause S; Lucka L; Voit T; Mitrani-Rosenbaum S; Hinderlich S
    Biochemistry; 2006 Mar; 45(9):2968-77. PubMed ID: 16503651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical characterization of human and murine isoforms of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE).
    Reinke SO; Eidenschink C; Jay CM; Hinderlich S
    Glycoconj J; 2009 May; 26(4):415-22. PubMed ID: 18815882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue expression and amino acid sequence of murine UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase.
    Horstkorte R; Nöhring S; Wiechens N; Schwarzkopf M; Danker K; Reutter W; Lucka L
    Eur J Biochem; 1999 Mar; 260(3):923-7. PubMed ID: 10103025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The collapsin response mediator protein 1 (CRMP-1) and the promyelocytic leukemia zinc finger protein (PLZF) bind to UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE), the key enzyme of sialic acid biosynthesis.
    Weidemann W; Stelzl U; Lisewski U; Bork K; Wanker EE; Hinderlich S; Horstkorte R
    FEBS Lett; 2006 Dec; 580(28-29):6649-54. PubMed ID: 17118363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy.
    Eisenberg I; Avidan N; Potikha T; Hochner H; Chen M; Olender T; Barash M; Shemesh M; Sadeh M; Grabov-Nardini G; Shmilevich I; Friedmann A; Karpati G; Bradley WG; Baumbach L; Lancet D; Asher EB; Beckmann JS; Argov Z; Mitrani-Rosenbaum S
    Nat Genet; 2001 Sep; 29(1):83-7. PubMed ID: 11528398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering sialic acid synthetic ability into insect cells: identifying metabolic bottlenecks and devising strategies to overcome them.
    Viswanathan K; Lawrence S; Hinderlich S; Yarema KJ; Lee YC; Betenbaugh MJ
    Biochemistry; 2003 Dec; 42(51):15215-25. PubMed ID: 14690432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A bifunctional enzyme catalyzes the first two steps in N-acetylneuraminic acid biosynthesis of rat liver. Molecular cloning and functional expression of UDP-N-acetyl-glucosamine 2-epimerase/N-acetylmannosamine kinase.
    Stäsche R; Hinderlich S; Weise C; Effertz K; Lucka L; Moormann P; Reutter W
    J Biol Chem; 1997 Sep; 272(39):24319-24. PubMed ID: 9305888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective loss of either the epimerase or kinase activity of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase due to site-directed mutagenesis based on sequence alignments.
    Effertz K; Hinderlich S; Reutter W
    J Biol Chem; 1999 Oct; 274(40):28771-8. PubMed ID: 10497249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterozygous UDP-GlcNAc 2-epimerase and N-acetylmannosamine kinase domain mutations in the GNE gene result in a less severe GNE myopathy phenotype compared to homozygous N-acetylmannosamine kinase domain mutations.
    Mori-Yoshimura M; Monma K; Suzuki N; Aoki M; Kumamoto T; Tanaka K; Tomimitsu H; Nakano S; Sonoo M; Shimizu J; Sugie K; Nakamura H; Oya Y; Hayashi YK; Malicdan MC; Noguchi S; Murata M; Nishino I
    J Neurol Sci; 2012 Jul; 318(1-2):100-5. PubMed ID: 22507750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from GNE-deficient embryonic stem cells: sialic acid biosynthesis is involved in proliferation and gene expression.
    Weidemann W; Klukas C; Klein A; Simm A; Schreiber F; Horstkorte R
    Glycobiology; 2010 Jan; 20(1):107-17. PubMed ID: 19797319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient metabolic oligosaccharide engineering of glycoproteins by UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) knock-down.
    Möller H; Böhrsch V; Lucka L; Hackenberger CP; Hinderlich S
    Mol Biosyst; 2011 Jul; 7(7):2245-51. PubMed ID: 21584309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinase C phosphorylates and regulates UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase.
    Horstkorte R; Nöhring S; Danker K; Effertz K; Reutter W; Lucka L
    FEBS Lett; 2000 Mar; 470(3):315-8. PubMed ID: 10745088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonaka myopathy is caused by mutations in the UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase gene (GNE).
    Kayashima T; Matsuo H; Satoh A; Ohta T; Yoshiura K; Matsumoto N; Nakane Y; Niikawa N; Kishino T
    J Hum Genet; 2002; 47(2):77-9. PubMed ID: 11916006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.